These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 31607242)

  • 41. Effect of Antiplatelet Therapy (Aspirin + Dipyridamole Versus Clopidogrel) on Mortality Outcome in Ischemic Stroke.
    Barlas RS; Loke YK; Mamas MA; Bettencourt-Silva JH; Ford I; Clark AB; Bowles KM; Metcalf AK; Potter JF; Myint PK
    Am J Cardiol; 2018 Sep; 122(6):1085-1090. PubMed ID: 30072125
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Combination antiplatelet agents for secondary prevention of ischemic stroke.
    Vande Griend JP; Saseen JJ
    Pharmacotherapy; 2008 Oct; 28(10):1233-42. PubMed ID: 18823219
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CSPS.com Trial of Adding Cilostazol to Antiplatelet Therapy to Reduce Recurrent Stroke.
    Hankey GJ
    Stroke; 2020 Feb; 51(2):696-698. PubMed ID: 31826736
    [No Abstract]   [Full Text] [Related]  

  • 44. The efficacy and safety of cilostazol in ischemic stroke patients with peripheral arterial disease (SPAD): protocol of a randomized, double-blind, placebo-controlled multicenter trial.
    Jeng JS; Sun Y; Lee JT; Lin RT; Chen CH; Po HL; Lin HJ; Liu CH; Sun MH; Sun MC; Chern CM; Lien LM; Chiu HC; Hu HH; Chiou HY; Chen ST; Ma H; Hsu CY;
    Int J Stroke; 2015 Jan; 10(1):123-7. PubMed ID: 25394855
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antithrombotic therapy for secondary prevention in patients with stroke or transient ischemic attack: A multiple treatment network meta-analysis of randomized controlled trials.
    Tornyos D; Komócsi A; Bálint A; Kupó P; El Abdallaoui OEA; Szapáry L; Szapáry LB
    PLoS One; 2022; 17(8):e0273103. PubMed ID: 35976963
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of antiplatelet and antithrombotic therapy for secondary prevention of ischemic stroke in patients with peripheral artery disease: population-based follow-up study in Taiwan.
    Lee WH; Chu CY; Hsu PC; Su HM; Lin TH; Voon WC; Lai WT; Sheu SH
    Circ J; 2013; 77(4):1046-52. PubMed ID: 23269006
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Early dual versus mono antiplatelet therapy for acute non-cardioembolic ischemic stroke or transient ischemic attack: an updated systematic review and meta-analysis.
    Wong KS; Wang Y; Leng X; Mao C; Tang J; Bath PM; Markus HS; Gorelick PB; Liu L; Lin W; Wang Y
    Circulation; 2013 Oct; 128(15):1656-66. PubMed ID: 24030500
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The efficacy and safety of cilostazol for the secondary prevention of ischemic stroke in acute and chronic phases in Asian population--an updated meta-analysis.
    Shi L; Pu J; Xu L; Malaguit J; Zhang J; Chen S
    BMC Neurol; 2014 Dec; 14():251. PubMed ID: 25527141
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cilostazol for Secondary Prevention of Stroke and Cognitive Decline: Systematic Review and Meta-Analysis.
    McHutchison C; Blair GW; Appleton JP; Chappell FM; Doubal F; Bath PM; Wardlaw JM
    Stroke; 2020 Aug; 51(8):2374-2385. PubMed ID: 32646330
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Aspirin Versus Aspirin Plus Clopidogrel as Antithrombotic Treatment Following Transcatheter Aortic Valve Replacement With a Balloon-Expandable Valve: The ARTE (Aspirin Versus Aspirin + Clopidogrel Following Transcatheter Aortic Valve Implantation) Randomized Clinical Trial.
    Rodés-Cabau J; Masson JB; Welsh RC; Garcia Del Blanco B; Pelletier M; Webb JG; Al-Qoofi F; Généreux P; Maluenda G; Thoenes M; Paradis JM; Chamandi C; Serra V; Dumont E; Côté M
    JACC Cardiovasc Interv; 2017 Jul; 10(13):1357-1365. PubMed ID: 28527771
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Use of cilostazol for secondary stroke prevention: an old dog with new tricks?
    Ansara AJ; Shiltz DL; Slavens JB
    Ann Pharmacother; 2012 Mar; 46(3):394-402. PubMed ID: 22353234
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antiplatelet regimens for Asian patients with ischemic stroke or transient ischemic attack: a systematic review and network meta-analysis.
    Jung SJ; Shim SR; Kim BJ; Jung JM
    Ann Transl Med; 2021 May; 9(9):753. PubMed ID: 34268366
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Aspirin Versus Clopidogrel for Type 2 Diabetic Patients with First-Ever Noncardioembolic Acute Ischemic Stroke: Ten-Year Survival Data from the Athens Stroke Outcome Project.
    Milionis H; Ntaios G; Papavasileiou V; Spengos K; Manios E; Elisaf M; Vemmos K
    J Stroke Cerebrovasc Dis; 2017 Dec; 26(12):2769-2777. PubMed ID: 28756905
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Addition of cilostazol reduces biological aspirin resistance in aspirin users with ischaemic stroke: a double-blind randomized clinical trial.
    Lee JH; Cha JK; Lee SJ; Ha SW; Kwon SU
    Eur J Neurol; 2010 Mar; 17(3):434-42. PubMed ID: 19922458
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antiplatelet therapy in the prevention of ischemic vascular events: literature review and evidence-based guidelines for drug selection.
    Zusman RM; Chesebro JH; Comerota A; Hartmann JR; Massin EK; Raps E; Wolf PA
    Clin Cardiol; 1999 Sep; 22(9):559-73. PubMed ID: 10486695
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy of antiplatelet therapy in secondary prevention following lacunar stroke: pooled analysis of randomized trials.
    Kwok CS; Shoamanesh A; Copley HC; Myint PK; Loke YK; Benavente OR
    Stroke; 2015 Apr; 46(4):1014-23. PubMed ID: 25721018
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy and safety of adjunctive cilostazol to dual antiplatelet therapy after stent implantation: an updated meta-analysis of randomized controlled trials.
    Ding XL; Xie C; Jiang B; Gao J; Zhang LL; Zhang H; Zhang JJ; Miao LY
    J Cardiovasc Pharmacol Ther; 2013 May; 18(3):222-8. PubMed ID: 23263383
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A comparative study of dual versus monoantiplatelet therapy in patients with acute large-artery atherosclerosis stroke.
    Yi X; Lin J; Wang C; Zhang B; Chi W
    J Stroke Cerebrovasc Dis; 2014 Aug; 23(7):1975-81. PubMed ID: 24739593
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Multicenter randomized trial evaluating the efficacy of cilostazol on ischemic vascular complications after drug-eluting stent implantation for coronary heart disease: results of the CILON-T (influence of CILostazol-based triple antiplatelet therapy ON ischemic complication after drug-eluting stenT implantation) trial.
    Suh JW; Lee SP; Park KW; Lee HY; Kang HJ; Koo BK; Cho YS; Youn TJ; Chae IH; Choi DJ; Rha SW; Bae JH; Kwon TG; Bae JW; Cho MC; Kim HS
    J Am Coll Cardiol; 2011 Jan; 57(3):280-9. PubMed ID: 21232664
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cilostazol Versus Aspirin in Ischemic Stroke Patients With High-Risk Cerebral Hemorrhage: Subgroup Analysis of the PICASSO Trial.
    Kim BJ; Kwon SU; Park JH; Kim YJ; Hong KS; Wong LKS; Yu S; Hwang YH; Lee JS; Lee J; Rha JH; Heo SH; Ahn SH; Seo WK; Park JM; Lee JH; Kwon JH; Sohn SI; Jung JM; Navarro JC; Kim HY; Kim EG; Kim S; Cha JK; Park MS; Nam HS; Kang DW;
    Stroke; 2020 Mar; 51(3):931-937. PubMed ID: 31856691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.